We use cookies to improve your browsing experience, gather website statistics, and provide more personalized services, both on this website and through other media. By using our website you accept our use of cookies. To find out more about the cookies we use, see our Cookie and Privacy Policy pages.
Author(s) |
(Date) |
Paper Title |
Citation |
Model Type |
Applications |
Full Text |
| Wu L, et al. Mouse over for full list Wu L, Zhang X, Zhao L |
(2018) | Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention. | J. Neurosci. | |||
| Jo DH, et al. Mouse over for full list Jo DH, Lee JH, Jun HJ, Kim J, Wen Q, Hoang MH, Yu YS, Kim JH, Lee SJ |
(2015) | Gene expression profiles of primary retinal pigment epithelial cells from apolipoprotein E knockout and human apolipoprotein E2 transgenic mice. | Genet. Mol. Res. 14(1):1855-67 | Knock out, Knock in |
Metabolism | |
| Tagalakis AD, et al. Mouse over for full list Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS |
(2001) | Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. | J. Biol. Chem. 276(16):13226-30 | Knock in |
Metabolism, Neuroscience, Alzheimer's | |
| Malek G, et al. Mouse over for full list Malek G, Johnson LV, Mace BE, Saloupis P, Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Bowes Rickman C |
(2005) | Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. | Proc. Natl. Acad. Sci. U.S.A. 102(33):11900-5 | |||
| Knouff C, et al. Mouse over for full list Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N |
(1999) | Apo E structure determines VLDL clearance and atherosclerosis risk in mice. | J. Clin. Invest. 103(11):1579-86 | |||
| Gerritsen G, et al. Mouse over for full list Gerritsen G, Kypreos KE, van der Zee A, Teusink B, Zannis VI, Havekes LM, van Dijk KW |
(2003) | Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain. | J. Lipid Res. 44(2):408-14 | |||
| Sullivan PM, et al. Mouse over for full list Sullivan PM, Mezdour H, Quarfordt SH, Maeda N |
(1998) | Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. | J. Clin. Invest. 102(1):130-5 |